https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
7% in 1999 to 49.8% in 2017 (P .0001). Most high-risk patients (60.3%) were treated with anticoagulants alone and did not receive an inferior vena cava filter. Mortality in these patients decreased from 79.0% in 1999 to 55.7% in 2017 (P .0001). Thrombolytic therapy was administered to 16.1% of high-risk patients, open pulmonary embolectomy alone was used in 4.3%, and extracorporeal membrane oxygenation was used in 0.4%. Mortality of high-risk patients with pulmonary embolism has decreased. This decrease can be at
Like
Comment
Share
